International Journal of Molecular SciencesNeurosciencePeer-reviewed journal article
RIPK2 is crucial for the microglial inflammatory response to bacterial muramyl dipeptide but not to lipopolysaccharide
Changjun YangiD, Maria Carolina Machado da SilvaiD, John Aaron HowelliD, Jonathan LarochelleiD, Lei LiuiD, Rachel E. GunrajiD, Antônio Carlos Pinheiro de OliveiraiD, Eduardo Candelario‐JaliliD
Abstract
Receptor-interacting serine/threonine protein kinase 2 (RIPK2) is a kinase that plays an essential role in the modulation of innate and adaptive immune responses. As a downstream signaling molecule for nucleotide-binding oligomerization domain 1 (NOD1), NOD2, and Toll-like receptors (TLRs), it is implicated in the signaling triggered by recognition of microbe-associated molecular patterns by NOD1/2 and TLRs. Upon activation of these innate immune receptors, RIPK2 mediates the release of pro-inflammatory factors by activating mitogen-activated protein kinases (MAPKs) and nuclear factor-kappa B (NF-{kappa}B). However, whether RIPK2 is essential for downstream inflammatory signaling following the activation of NOD1/2, TLRs, or both remains controversial. In this study, we examined the role of RIPK2 in NOD2- and TLR4-dependent signaling cascades following stimulation of microglial cells with bacterial muramyl dipeptide (MDP), a NOD2 agonist, or lipopolysaccharide (LPS), a TLR4 agonist. We utilized a highly specific proteolysis targeting chimera (PROTAC) molecule, GSK3728857A, and found dramatic degradation of RIPK2 in a concentration- and time-dependent manner. Importantly, the PROTAC completely abolished MDP-induced increases in iNOS and COX-2 protein levels and pro-inflammatory gene transcription of Nos2, Ptgs2, Il-1{beta}, Tnf, Il6, Ccl2, and Mmp9. However, increases in iNOS and COX-2 proteins and pro-inflammatory gene transcription induced by the TLR4 agonist, LPS, were only slightly attenuated with the GSK3728857A pretreatment. Further findings revealed that the RIPK2 PROTAC completely blocked the phosphorylation and activation of p65 NF-{kappa}B and p38 MAPK induced by MDP, but it had no effects on the phosphorylation of these two mediators triggered by LPS. Collectively, our findings strongly suggest that RIPK2 plays an essential role in the inflammatory responses of microglia to bacterial MDP but not to LPS.
- Citations
- 4
- FWCI
- 0.67
- Field percentile
- top 34%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures
K. Ellwanger, C. Arnold, … T. A. Kufer·bioRxiv·Feb 8, 2019
- LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infection
C. G. Weindel, S. L. Bell, … R. O. Watson·bioRxiv·Jul 26, 2019
- K27-linked ubiquitination restrains the NOD2-RIP2 signaling pathway
Swarupa Panda, Amitha Kamath, Nelson O. Gekara·bioRxiv·Jan 20, 2026
- A regulatory interface on RIPK2 is required for XIAP binding and NOD signaling activity
V. J. Heim, L. F. Dagley, … U. Nachbur·bioRxiv·Mar 12, 2020
- Activation of the pro-resolving receptors Fpr2/3 attenuate lipopolysaccharide-induced inflammatory microglial activation
Edward S. Wickstead, Bradley Elliott, … Simon McArthur·bioRxiv·Jul 9, 2020
- NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-presentation and CD8 T Cell Responses
D. Corridoni, S. Shiraishi, … A. Simmons·bioRxiv·Mar 8, 2019